期刊
BIOMOLECULES
卷 11, 期 5, 页码 -出版社
MDPI
DOI: 10.3390/biom11050767
关键词
natural products; epigallocatechin-3-gallate; catechins; neuroprotective; anti-neurodegenerative; anti-amyloidogenic; misfolded proteins; amyloid-beta; alpha-synuclein; Alzheimer's disease; Parkinson's disease
资金
- National Council for Scientific and Technological Development (CNPq)
- National Council for the Improvement of Higher Education (CAPES) [001]
- Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ)
The major bioactive compound EGCG in green tea shows potential for treating neurodegenerative diseases by targeting protein misfolding and aggregation. There is an urgent need to develop effective drugs for these incurable ailments, and EGCG may offer opportunities in drug discovery for NDs.
The potential to treat neurodegenerative diseases (NDs) of the major bioactive compound of green tea, epigallocatechin-3-gallate (EGCG), is well documented. Numerous findings now suggest that EGCG targets protein misfolding and aggregation, a common cause and pathological mechanism in many NDs. Several studies have shown that EGCG interacts with misfolded proteins such as amyloid beta-peptide (A beta), linked to Alzheimer's disease (AD), and alpha-synuclein, linked to Parkinson's disease (PD). To date, NDs constitute a serious public health problem, causing a financial burden for health care systems worldwide. Although current treatments provide symptomatic relief, they do not stop or even slow the progression of these devastating disorders. Therefore, there is an urgent need to develop effective drugs for these incurable ailments. It is expected that targeting protein misfolding can serve as a therapeutic strategy for many NDs since protein misfolding is a common cause of neurodegeneration. In this context, EGCG may offer great potential opportunities in drug discovery for NDs. Therefore, this review critically discusses the role of EGCG in NDs drug discovery and provides updated information on the scientific evidence that EGCG can potentially be used to treat many of these fatal brain disorders.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据